Amgen is an international biotechnology company that makes an active contribution to better care. Amgen scientists have been developing innovative therapies for patients with serious illnesses since 1980. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases and cardiovascular diseases.
Amgen is active in around 100 countries worldwide. Amgen Saudi Arabia Limited has started its journey in the Saudi market since 2017, with the opening of Amgen Scientific Office in the city of Riyadh to transform into (Amgen Saudi Arabia Limited) by the year 2020 after obtaining a foreign investment license.
We are responsible for the availability of our medicines for the patients in Saudi Arabia
Amgen has built up an excellent, worldwide reputation in the area of biologics - medicines made using biotechnological techniques. Amgen supplies high-quality medicines and focuses primarily on patients with conditions for which few or no treatment options exist. It takes expertise, experience, vigilance and dedication to ensure that every new batch of biologic medicines is of the same high quality. At Amgen, strict quality control and a reliable supply of medicines are just as important as scientific innovation.